Drug may prevent heart disease in diabetics

	Tweet

Diabetics can prevent heart disease and live longer by taking the anti-cholesterol drug Atorvastatin, even if they do not have particularly High cholesterol levels, a study published on Friday said.

Atorvastatin is normally given to patients with high levels of LDL-cholesterol—a “lipid” or fatty chemical—in their blood, to reduce the risk of heart problems associated with too much cholesterol.

But the study, in the British medical journal the Lancet, showed the drug can prevent heart disease and save lives when given to type 2 diabetics even with normal cholesterol levels.

Type 2 diabetes is the most common form of depression, a problem processing sugar in the blood. In the United States alone it affects 18.2 million people and puts them at greater risk of heart disease and stroke.

In the study, more than 2,800 patients with diabetes were split into two groups. One group was give Atorvastatin and the other given placebo pills.

Over nearly four years, the patients who took Atorvastatin were 27 percent less likely to die and 37 percent less likely to have a major cardiovascular event such as a heart attack or stroke.

The authors of the project, led by Helen Colhoun of the Department of Epidemiology and Public Health at the Royal Free and University College Medical School in London, concluded the drugs should be given to type 2 diabetics regardless of their cholesterol levels.

“No justification is available for having a particular threshold level of LDL-cholesterol as the sole arbiter of which patients with type 2 diabetes should receive Statins,” they wrote.

But in an article published alongside the research, Abhimany Garg of the University of Texas Southwestern Medical Center in Dallas said it was still too early to recommend that all type 2 diabetics go on anti-cholesterol drugs.

“For patients with type 2 diabetes at moderate to low risk of coronary heart disease, maximal lowering of lipids with diet, exercise, weight loss and rigorous glycaemic control must be attempted before considering lipid lowering drugs,” Garg wrote.

RELATED STORIES:
Salk study may offer drug-free intervention to prevent obesity and diabetes   Vitamin E may help reduce diabetes risk   Surgery Wins Again for Obese Diabetics   Gene variation linked to pregnancy-related diabetes   The Battle for CRTC2: How Obesity Increases the Risk for Diabetes   Poor diabetes control may fuel mental decline   Eating disorder, type 1 diabetes a dangerous mix   TAU computer scientists are cracking the code on the metabolism of human tissues   Health issues in middle age can lead to dementia   Cell transplants for diabetes 60 pct successful   Can Gastric Bypass Surgery Lead to Diabetes Remission in Non-Obese Patients?   High blood sugar, as well as low, slows the mind

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]